AFT Pharmaceuticals (ASX:AFP) Reports Record Annual Revenue
AFT Pharmaceuticals (ASX:AFP) reports a 6% increase in FY25 revenue, targets $300M by FY27, and declares an increased dividend.
Category: ASX-AFP
AFT Pharmaceuticals
Latest News
BetMakers Technology Group (ASX:BET) Releases Q3 FY25 Trading Update
Australis Oil & Gas Limited (ASX: ATS) Announces 2024 Financial and ESG Results
Hutchison Telecommunications (Australia) Limited (ASX:HTA) Announces Takeover Offer
Victory Metals Limited (ASX:VTM) Responds to ASX Query
MA Financial Group Limited (ASX:MAF) Acquires IP Generation
Solis Minerals (ASX:SLM) Mobilises Drill Rig to Peru
Dimerix (ASX:DXB) Successfully Completes IDMC Review for ACTION3 Phase 3 Trial
Kali Metals (ASX:KM1) Expands Pilbara Gold Project with Strategic Acquisition
Betr Entertainment Limited (ASX:BBT) Completes $130M Equity Raising
Hillgrove Resources Limited (ASX:HGO) Reports New High Grade Copper-Gold Drilling Results
The Hub of Australian Finance News